Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.

Erriquez, Jessica; Olivero, M; Mittica, Gloria; Scalzo, Ms; Vaira, M; De Simone, M; Ponzone, R; Katsaros, D; Aglietta, Massimo; Calogero, Raffaele Adolfo; Di Renzo, Maria Flavia; Valabrega, Giorgio

doi:10.18632/oncotarget.8325

Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.

By Jessica Erriquez, M Olivero, Gloria Mittica, Ms Scalzo, M Vaira, M De Simone, R Ponzone, D Katsaros, Massimo Aglietta, Raffaele Adolfo Calogero, Maria Flavia Di Renzo and Giorgio Valabrega

Get PDF (5 MB)

Topics: chemotherapy; ovarian cancer; patient derived xenograft

Publisher: 'Impact Journals, LLC'

Year: 2016

DOI identifier: 10.18632/oncotarget.8325

OAI identifier: oai:iris.unito.it:2318/1589539

Provided by: Institutional Research Information System University of Turin

Downloaded from https://iris.unito.it/bitstream/2318/1589539/1/Oncotarget%202016_Erriquez%20J%20et%20al.pdf

Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.

Suggested articles